I thought a StreetSweeper article would be out. I still think rise in sp was partially done by manipulators to try to get momentum buying going so the could short a larger top. Good to see it's holding.
Yet another possibility. The stock is low enough for a fake rally to bring in momentum traders. What follows would be attack articles and a big short. I would hope this is not the case but be cautious on share price rising without news.
$2.999999999mm to lawyers (sarcasm)....$1 to shareholders.....but $3mm less worth of company to shareholders....the win is a net loss....always is.
Yes there are good results with those $50,000 a year drugs that dampen down the immune system to the point you endanger the patients with cancer and TB
The ph-10 study was limited in treatment time compared to the others
And ph-10 has ZERO side effects
And costs less than a nickel to make
You were saying?
By all means I hope you short it....don't talk... Do it!
Must be why pfizer just added their third exec to the sab in addition to the four other ex-pfizer execs now on the sab. Your brilliantly stupid,
No one else is doing that....exactly....an unmet need that's 95% of the market
Stage four is only about 5% of the market that all the immunotherapies are alloted..... A dozen therapies for stage four...none for local regional control.... Nttg sometimes you astound me with sayimg dumb things when you should know better.
They still have a $50mm credit line with cantor so if they choose that route they have money to go to the end...albeit with dilution
PH-10 is a moa study thus the low enrollment...this is being done to add value to big pharma because they like knowing how it works
Start of p3 melanoma is important but liver will probably end sooner
Breast? Not happening anytime soon....that's much later
The big thing is getting China and India license done...which should be sooner than later
The patent in China was awarded now they need liver protocols done and final p3 protocols for melanoma which are likely done.
No investors are going to move until these milestones are met
Once met we should see movement but not until then
No buyout is coming any time soon
Patent accepted in China probably means China licensing deal can move forward
Liver protocols may be done now
Probably and maybe is all that we have at this time
A big pharma is going to need p3 data....some....interim....or the finished p3
Pvct is a company
They are not allowed to apply without p3 data
The one time they got in was an exception
Your sarcasm is duly and fully noted. And I will agree the delay in progress is very frustrating from a shareholder point of view. That being said ...things are happening
What's wrong with the videos? Because they are three years dated?
Cancer has not changed since then.... But does there need to be new videos...maybe...investors always want info current... The cancer is the same. What has changed?
Your a smart guy...be realistic